Tseng William W, Seo Hyun Jae, Pollock Raphael E, Gronchi Alessandro
Department of Surgery, Section of Surgical Oncology, Keck School of Medicine, University of Southern California, Los Angeles, California.
Department of Surgery, The James Comprehensive Cancer Center, Ohio State University, Columbus, Ohio.
J Surg Oncol. 2018 Jan;117(1):7-11. doi: 10.1002/jso.24888. Epub 2017 Nov 11.
Retroperitoneal sarcomas (RPS) have fascinated and intrigued physicians both past and present. Operative mortality rates were historically very high and complete resection was not possible for the majority of patients until only the last 2 decades. More recently, changes to the surgical approach and clinical decision-making in RPS have improved patient outcomes. With select integration of nonsurgical therapies, continued RPS-specific research, and ongoing collaborative efforts among major referral centers, the future appears promising.
腹膜后肉瘤（RPS）一直吸引着古今的医生。从历史上看，手术死亡率非常高，直到过去20年，大多数患者都无法实现完全切除。最近，腹膜后肉瘤手术方法和临床决策的改变改善了患者的预后。通过有选择地整合非手术治疗、持续开展针对腹膜后肉瘤的研究以及主要转诊中心之间持续的合作努力，未来看起来很有希望。
